| |
| |
| Exchange: |
Nasdaq National Market |
| Security
Type: |
Common |
| Shares
Out: |
138,140,000 |
| Market
Cap: |
142.28(M) |
| Last
Volume: |
3,241,097 |
Avg
Vol: |
3,286,692 |
| 52
Week Range: |
$0.92 - $1.31 |
|
| Level
I Sector: |
Health Care |
| Level
II Sector: |
Drugs |
| Level
III Sector: |
Drug Manufacturers - Major |
|
Member Indexes:
|
| |
NASDAQ COMPOSITE |
|
NASDAQ NNM COMPOSITE |
|
Rankings:
|
|
| Insider 3 Months : - |
| Insider 6 Months : - |
| Insider 3/6 Months : - |
|
| Guru Rank Number : 807 |
| Guru Rank Value : 1 |
| Guru Occurances : 1 |
|
|
|
|
|
| |
|
Company Profile Spectrum Pharmaceuticals is a biopharmaceutical company. Co. is engaged in acquiring, developing, and commercializing targeted oncology therapies. Co. has two drugs in late-stage development: Eflapegrastim, which is a long-acting granulocyte colony-stimulating factor for the treatment of chemotherapy-induced neutropenia; as well as Poziotinib, which is an irreversible tyrosine kinase inhibitor under investigation for non-small cell lung cancer tumors with various mutations.
|
|
|
D/I:
|
|
|
D
is for direct shares.
I is
for indirect shares.
D/I
refers to the Direct or Indirect
shares traded vs. held. |
|
|
|
Forms:
|
|
|
A
Form 4 is a form filed
by an insider to indicate a change
in ownership.
A Form
3 is a form filed by
an insider to indicate an
initial ownership of a security. |
|
|
|
3m +/-:
|
|
|
|
This
represents the company's 3 month
price change. The initial price
is based on the closing price
of the stock on the day the transaction
took place. Purchases & sales
are viewed as long & short
positions respectively.
|
|
|
|
Actions:
|
|
|
| B |
Buy |
| S |
Sell |
| OE |
Option
Exercised |
| A |
Acquired |
| D |
Disposed |
| AB |
Automatic
Buy |
| AS |
Automatic
Sell |
| IO |
Initial
Ownership |
|
|
|
|
Download:
|
|
|
Download only Transactions
Forms. (Default)
Download
only Summary Infomation.
Download
both Transactions and Summary Data
|
|
|
|
|
| |
| |
Summary (Direct Transactions Only)  |
3 Months |
6 Months |
12 Months |
24 Months |
| Total Shares Bought |
0 |
0 |
0 |
50,000 |
| Total Buy Value |
$0 |
$0 |
$0 |
$22,500 |
| Total People Bought |
0 |
0 |
0 |
1 |
| Total Buy Transactions |
0 |
0 |
0 |
1 |
| Total Shares Sold |
0 |
0 |
32,387 |
490,738 |
| Total Sell Value |
$0 |
$0 |
$35,496 |
$343,474 |
| Total People Sold |
0 |
0 |
1 |
7 |
| Total Sell Transactions |
0 |
0 |
1 |
19 |
| End Date |
2024-01-28 |
2023-10-27 |
2023-04-28 |
2022-04-28 |
|
| Filer's Name |
Relation Title |
Off-Dir-10% |
Tran. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
| 3m +/- |
|
|
Form |
  Mcgahan Keith M |
SVP and Chief Legal Officer |
• – – |
2019-02-07 |
4 |
AS |
$11.03 |
$27,541 |
D/D |
(2,496) |
103,577 |
|
- |
|
| Maida Anthony E III |
Director |
– • – |
2019-01-24 |
4 |
AS |
$10.37 |
$75,183 |
D/D |
(7,250) |
32,988 |
|
- |
|
| Maida Anthony E III |
Director |
– • – |
2019-01-24 |
4 |
OE |
$3.92 |
$34,861 |
D/D |
7,250 |
38,688 |
|
- |
|
| Vyas Dolatrai |
Director |
– • – |
2019-01-22 |
4 |
S |
$10.62 |
$63,826 |
D/D |
(6,010) |
41,069 |
|
- |
|
| Turgeon Joseph W. |
CEO & President |
• • – |
2019-01-16 |
4 |
AS |
$10.44 |
$53,135 |
D/D |
(5,091) |
408,541 |
|
- |
|
| Gustafson Kurt A |
EVP & Chief Financial Officer |
• – – |
2019-01-16 |
4 |
AS |
$10.44 |
$33,471 |
D/D |
(3,207) |
216,896 |
|
- |
|
| Riga Thomas J |
EVP, COO & CCO |
• – – |
2019-01-16 |
4 |
AS |
$10.44 |
$109,578 |
D/D |
(10,499) |
231,083 |
|
- |
|
| Turgeon Joseph W. |
CEO & President |
• • – |
2019-01-11 |
4 |
AS |
$10.87 |
$394,810 |
D/D |
(36,311) |
413,632 |
|
- |
|
| Gustafson Kurt A |
EVP & Chief Financial Officer |
• – – |
2019-01-11 |
4 |
AS |
$10.87 |
$366,333 |
D/D |
(33,692) |
220,103 |
|
- |
|
| Turgeon Joseph W. |
CEO & President |
• • – |
2019-01-09 |
4 |
A |
$0.00 |
$0 |
D/D |
133,434 |
449,943 |
|
- |
|
| Gustafson Kurt A |
EVP & Chief Financial Officer |
• – – |
2019-01-09 |
4 |
A |
$0.00 |
$0 |
D/D |
100,326 |
253,795 |
|
- |
|
| Maida Anthony E III |
Director |
– • – |
2019-01-07 |
4 |
AS |
$10.00 |
$72,500 |
D/D |
(7,250) |
32,988 |
|
- |
|
| Maida Anthony E III |
Director |
– • – |
2019-01-07 |
4 |
OE |
$3.92 |
$28,420 |
D/D |
7,250 |
40,238 |
|
- |
|
| Maida Anthony E III |
Director |
– • – |
2018-12-06 |
4 |
AS |
$12.60 |
$91,350 |
D/D |
(7,250) |
32,988 |
|
- |
|
| Maida Anthony E III |
Director |
– • – |
2018-12-06 |
4 |
OE |
$3.92 |
$28,420 |
D/D |
7,250 |
40,238 |
|
- |
|
| Vacirca Jeff L |
Director |
– • – |
2018-11-30 |
4 |
A |
$0.00 |
$0 |
D/D |
6,667 |
16,967 |
|
- |
|
| Ashton William |
Director |
– • – |
2018-11-30 |
4 |
A |
$0.00 |
$0 |
D/D |
3,333 |
13,333 |
|
- |
|
| Maida Anthony E III |
Director |
– • – |
2018-11-08 |
4 |
AS |
$13.07 |
$94,758 |
D/D |
(7,250) |
32,988 |
|
- |
|
| Maida Anthony E III |
Director |
– • – |
2018-11-08 |
4 |
OE |
$3.92 |
$28,420 |
D/D |
7,250 |
40,238 |
|
- |
|
| Gagnon Gilles |
Director |
– • – |
2018-10-09 |
4 |
S |
$15.33 |
$153,349 |
D/D |
(10,000) |
72,500 |
|
- |
|
| Mcgahan Keith M |
SVP and Chief Legal Officer |
• – – |
2018-08-08 |
4 |
AS |
$20.96 |
$9,160 |
D/D |
(437) |
105,993 |
|
- |
|
| Riga Thomas J |
EVP, COO & CCO |
• – – |
2018-06-25 |
4 |
AS |
$18.76 |
$4,408 |
D/D |
(235) |
240,263 |
|
- |
|
| Krassner Stuart Mitchell |
Director |
– • – |
2018-06-18 |
4 |
A |
$0.00 |
$0 |
D/D |
10,000 |
67,944 |
|
- |
|
| Mcgahan Keith M |
SVP and Chief Legal Officer |
• – – |
2018-06-18 |
4 |
A |
$0.00 |
$0 |
D/D |
45,000 |
106,393 |
|
- |
|
| Welles Bernice R |
Director |
– • – |
2018-06-18 |
4 |
A |
$0.00 |
$0 |
D/D |
10,000 |
10,000 |
|
- |
|
658 Records found
|
|
Page 10 of 27 |
|
|
